Literature DB >> 21286868

Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial.

Tami D Benton1.   

Abstract

Entities:  

Year:  2011        PMID： 21286868     DOI： 10.1007/s11920-010-0172-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  9 in total

1.  Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Autism and other Pervasive Developmental Disorders. American Academy of Child and Adolescent Psychiatry.

Authors:  F Volkmar; E Cook; J Pomeroy; G Realmuto; P Tanguay
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-12       Impact factor: 8.829

2.  Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification.

Authors:  Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2006-11

3.  Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.

Authors:  Maria R Valicenti-McDermott; Howard Demb
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-10       Impact factor: 2.576

4.  Aripiprazole for maladaptive behavior in pervasive developmental disorders.

Authors:  Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2004       Impact factor: 2.576

5.  Pervasive developmental disorders in preschool children: confirmation of high prevalence.

Authors:  Suniti Chakrabarti; Eric Fombonne
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

6.  Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Authors:  Sarah Shea; Atilla Turgay; Alan Carroll; Miklos Schulz; Herbert Orlik; Isabel Smith; Fiona Dunbar
Journal:  Pediatrics       Date:  2004-10-18       Impact factor: 7.124

7.  Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Authors:  Randall Owen; Linmarie Sikich; Ronald N Marcus; Patricia Corey-Lisle; George Manos; Robert D McQuade; William H Carson; Robert L Findling
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

Review 8.  Management of children with autism spectrum disorders.

Authors:  Scott M Myers; Chris Plauché Johnson
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

9.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245
  9 in total
  3 in total

Review 1.  Aripiprazole for autism spectrum disorders (ASD).

Authors:  Lauren E Hirsch; Tamara Pringsheim
Journal:  Cochrane Database Syst Rev       Date:  2016-06-26

2.  A randomised controlled trial of bumetanide in the treatment of autism in children.

Authors:  E Lemonnier; C Degrez; M Phelep; R Tyzio; F Josse; M Grandgeorge; N Hadjikhani; Y Ben-Ari
Journal:  Transl Psychiatry       Date:  2012-12-11       Impact factor: 6.222

Review 3.  Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.

Authors:  Ahmad Ghanizadeh; Sylvie Tordjman; Nematollah Jaafari
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.